Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-01-13 16:11 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Property, Asia, China, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
SciNeuro’s anti-amyloid programme is one of the firm’s key strategic research and development priorities to target the brain disease
--------------------------------------------------------------------